TSXV/EKG (TSXV/EKG)

TSX Venture Exchange: TSXV/EKG · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	2M
Revenue (ttm)	280.4K
Net income (ttm)	-661.7K
EPS (ttm)	-CA$0.00
Shares out	197.6M
Volume	0
Beta	-1.94

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 280.4K
Net income (ttm): -661.7K
EPS (ttm): -CA$0.00
Market cap: 2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROIC-775.9

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All TSXV/EKG indicators

Market & fundamental data

Available fields

161

Groups with data

Currency

CAD

Showing 161 of 161 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Employees	16
Enterprise value	CAD 2.9M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1989
Industry	Health Information Services
Is primary listing	Yes
ISIN number	CA14159N2086
Last earnings date	2025-11-28
Last refreshed	2026-10-29
Last stock split date	2007-11-26
Last stock split type	Reverse
Market cap	CAD 2M
Next earnings date	2026-11-27
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	7373
Stock price date	2026-10-27
Symbol	tsxv/EKG
Website	https://cardiocommsolutions.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-33.56%
EV/Sales	10.2x
FCF / EV yield	-13.73%
FCF yield	-19.88%
P/S ratio	7.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-184.74%
EBITDA margin	-183.84%
Gross margin	76.86%
Operating margin	-184.74%
Pretax margin	-236.02%
Profit margin	-236.02%
Profit per employee	CAD -41,356
Revenue per employee	CAD 17,522
ROA	-154.78%
ROA (5Y)	-56.39%
ROCE	89.21%
ROIC	-775.95%
SBC / revenue	0.89%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-51.48%
Gross profit growth (Q)	29.17%
Gross profit growth 3Y	-28.65%
Gross profit growth 5Y	-20.15%
Revenue growth	-41.89%
Revenue growth (Q)	25.13%
Revenue growth (QoQ)	0%
Revenue growth 10Y	-15.41%
Revenue growth 3Y	-30.4%
Revenue growth 5Y	-17.77%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -3,154
Depreciation and amortization	CAD 2,511
EBIT	CAD -517,921
EBITDA	CAD -515,410
EPS	CAD -0.00
FCF per share	CAD -0.00
Financing cash flow	CAD 383,690
Free cash flow	CAD -392,806
Free cash flow minus SBC	CAD -395,303
Gross profit	CAD 215,471
Investing cash flow	CAD -3,154
Net borrowing	CAD 383,690
Net cash flow	CAD -9,116
Net income	CAD -661,701
Operating cash flow minus SBC	CAD -392,149
Operating income	CAD -517,921
Revenue	CAD 280,355
Stock-based compensation	CAD 2,497

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-268.48
Book value per share	CAD -0.00
Interest coverage	-6.36
Long-term assets	CAD 9,148
Long-term liabilities	CAD 383,425
Net cash (debt)	CAD -884,156
Net cash / market cap	-44.75%
Piotroski F-Score	1
Property, plant and equipment	CAD 7,152
Shareholders' equity	CAD -964,004
Tangible book value	CAD -966,000
Tangible book value per share	CAD -0.00
Total assets	CAD 196,205
Total cash	CAD 38,345
Total debt	CAD 922,501
Total liabilities	CAD 1.2M
WACC	-2.15%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.34
Current assets	CAD 187,057
Current liabilities	CAD 776,784
Current ratio	0.24
Inventory turnover	3.28
Net working capital	CAD -88,996
Quick ratio	0.19
Working capital	CAD -589,727
Working capital turnover	-0.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.58%
Shareholder yield	-2.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-75%
10Y return CAGR	-12.95%
10Y total return	-75%
150-day SMA	CAD 0.01
15Y price change	-77.78%
15Y return CAGR	-9.54%
15Y total return	-77.78%
1D price change	0%
1Y price change	-33.33%
1Y return CAGR	-33.35%
1Y total return	-33.33%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.01
20Y price change	-93.33%
20Y return CAGR	-12.66%
20Y total return	-93.33%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.02
52-week high date	2026-07-17
52-week low	CAD 0.01
52-week low date	2026-10-14
5Y price change	-75%
5Y return CAGR	-24.22%
5Y total return	-75%
All-time high	CAD 38.25
All-time high date	1996-05-02
All-time low	CAD 0.01
All-time low date	2023-11-14
Average true range (ATR)	CAD 0.00
Average volume	69.4K
Beta (1Y)	4.67
Beta (2Y)	3.07
Beta (5Y)	-1.94
Change from 52-week high	-33.33%
Change from 52-week low	100%
Change from all-time high	-99.97%
Change from all-time low	100%
Monthly RSI	48.3
Previous close	CAD 0.01
Price vs 150-day SMA	-2.91%
Price vs 20-day SMA	7.53%
Price vs 200-day SMA	-3.85%
Price vs 50-day SMA	-1.96%
Relative volume	0.26
RSI	52.48
Sharpe ratio	1.93
Sharpe ratio (3Y)	1.47
Sharpe ratio (5Y)	1.15
Sortino ratio	3.8
Sortino ratio (3Y)	2.78
Sortino ratio (5Y)	2.15
Volume	0
Weekly RSI	50.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	111.2M
Shares change (QoQ)	0%
Shares change (YoY)	2.58%
Shares held by insiders	27.73%
Shares outstanding	197.6M

Deeper analysis on TSXV/EKG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/EKG report

Is a complete TSXV/EKG research report available?

No complete published report is available for tsxv/EKG (TSXV/EKG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/EKG (TSXV/EKG)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/EKG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/EKG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/EKG

Frequently asked questions